Toxicodynamics of tumour promoters of mouse skin. III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay
- PMID: 1533861
- PMCID: PMC12201524
- DOI: 10.1007/BF01294438
Toxicodynamics of tumour promoters of mouse skin. III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay
Abstract
A method is described for measuring rapid, specific, and saturable binding of the skin irritant and tumour-promoting secretagogue thapsigargin (sesquiterpene lactone) to the microsomal fraction from mouse brain. Employing the tritium-labelled compound its apparent dissociation constant, Kd, and the maximal amount of binding Bmax are shown to be 9.8 nM and 1.9 pmol/mg protein respectively. Such a Kd for thapsigargin is similar to (a) its IC50 value for inhibiting Ca2+ uptake in the microsomal fraction from rat brain and (b) its EC50 values for inducing a rise in the cytoplasmic Ca2+ concentration of human platelets and histamine release from rat peritoneal mast cells. A positive correlation is found between the binding affinities of thapsigargin, thapsitranstagin, and trilobolide, their potencies as secretagogues and their lipophilicities. This correlation does not extend to the skin-irritant activities of the compounds thus emphasizing that their mechanism of action is unlike that of 12-O-tetradecanoylphorbol 13-acetate.
Similar articles
-
Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis.J Cancer Res Clin Oncol. 1986;111(3):177-81. doi: 10.1007/BF00389230. J Cancer Res Clin Oncol. 1986. PMID: 2426275 Free PMC article.
-
Toxicodynamics of tumour promoters of mouse skin. II. Binding to protein kinase C of some new diterpene esters and induction of luminol-enhanced chemoluminescence in mouse peritoneal neutrophils.J Cancer Res Clin Oncol. 1991;117(5):385-95. doi: 10.1007/BF01612756. J Cancer Res Clin Oncol. 1991. PMID: 1653779 Free PMC article.
-
Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol-13-acetate) (TPA)-type tumor promoter.J Cancer Res Clin Oncol. 1987;113(4):319-24. doi: 10.1007/BF00397715. J Cancer Res Clin Oncol. 1987. PMID: 3110174 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- Ashendel CL, Boutwell RK (1981) Direct measurement of specific binding of highly lipophilic phorbol diester to mouse epidermal membranes using cold acetone. Biochem Bophys Res Commun 99:543–549 - PubMed
-
- Bennett JP (1978) Methods in binding studies in neurotransmitter receptor binding. In: Yamamura HI, Enna SJ, Kuhar MJ (eds) Neurotransmitter receptor binding. Raven Press, New York, pp 57–90
-
- Christensen SB (1985) Radiolabelling of the histamine liberating sesquiterpene lactone, thapsigargin. J Labelled Compd Radiopharm 22:71–77
-
- Christensen SB, Andersen A, Lauridsen A, Moldt P, Smitt U, Thastrup O (1992) Thapsigargin a lead to design of drugs with the calcium pump as target. In: Krogsgaard-Larsen P, Christensen SB, Kofod H (eds) New lead and targets in drug design. Munksgaard, Copenhagen (in press)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous